Anti-TMC8 antibody
-
概述
- 产品描述Epidermodysplasia verruciformis (EV) is an autosomal recessive dermatosis characterized by abnormal susceptibility to human papillomaviruses (HPVs) and a high rate of progression to squamous cell carcinoma on sun-exposed skin. EV is caused by mutations in either of two adjacent genes located on chromosome 17q25. 3. Both of these genes encode integral membrane proteins that localize to the endoplasmic reticulum and are predicted to form transmembrane channels. This gene encodes a transmembrane channel-like protein with 8 predicted transmembrane domains and 3 leucine zipper motifs.
- 产品名称Anti-TMC8 antibody
- 分子量81 kDa
- 种属反应性Human, Mouse, Rat
- 验证应用WB, IHC-P
- 抗体类型兔多抗
- 免疫原The antiserum was produced against synthesized peptide derived from human TMC8. AA range:601-650
- 偶联Non-conjugated
-
性能
- 形态Liquid
- 浓度1 mg/mL.
- 存放说明Store at +4℃ after thawing. Aliquot store at -20℃ or -80℃. Avoid repeated freeze / thaw cycles.
- 存储缓冲液Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
- 亚型IgG
- 纯化方式Immunogen affinity purified.
- 其它名称
- TMC8 antibody; EVER2 antibody; EVIN2 antibody; Transmembrane channel-like protein 8 antibody; Epidermodysplasia verruciformis protein 2 antibody;
-
应用
WB: 1:500-1:2000
IHC-P: 1:100-1:300
-
Fig1: Western Blot analysis of HeLa cells using TMC8 Polyclonal Antibody. Secondary antibody(catalog#:HA1001) was diluted at 1:20000
特别提示:本公司的所有产品仅可用于科研实验,严禁用于临床医疗及其他非科研用途!